After failing to hit the primary endpoint in a Phase III trial, Neumora is remixing study parameters in two replicate trials, ...
TMS of Central Florida, a leading treatment center in Brandon, is offering cutting-edge therapy to help local residents ...
Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
Psilocybin-assisted psychotherapy significantly improved a range of psychiatric symptoms among people with cancer, according ...
After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...
Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...
12d
Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback